Literature DB >> 10953042

Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives.

M Pusch1, A Liantonio, L Bertorello, A Accardi, A De Luca, S Pierno, V Tortorella, D C Camerino.   

Abstract

The enantiomers of 2-(p-chlorophenoxy)propionic acid (CPP) and of its analogs with substitutions on the asymmetric carbon atom were tested on human ClC-1 channel, the skeletal muscle chloride channel, after heterologous expression in Xenopus laevis oocytes, to gain insight in the mechanism of action of these stereoselective modulators of macroscopic chloride conductance (gCl) of rat striated fibers. By means of two microelectrode voltage clamp recordings, we found that S(-)-CPP shifted the activation curve of the ClC-1 currents toward more positive potentials and decreased the residual conductance at negative membrane potential; both effects probably account for the decrease of gCl at resting potential of native muscle fibers. Experiments on expressed Torpedo marmorata ClC-0 channels and a mutant lacking the slow gate suggest that S(-)-CPP could act on the fast gate of the single protochannels constituting the double-barreled structure of ClC-0 and ClC-1. The effect of S(-)-CPP on ClC-1 was markedly increased at low external pH (pH = 6), possibly for enhanced diffusion through the membrane (i.e., because the compound was effective only when applied to the cytoplasmic side during patch clamp recordings). The R(+)-isomer had little effect at concentrations as high as 1 mM. The CPP analogs with an ethyl, a phenyl, or an n-propyl group in place of the methyl group on the asymmetric center showed a scale of potency and a stereoselective behavior on ClC-1 similar to that observed for blocking gCl in native muscle fibers. The tested compounds were selective toward the ClC-1 channel. In fact, they were almost ineffective on an N-terminal deletion mutant of ClC-2 that is volume- and pH-independent while they blocked wild-type ClC-2 currents only at high concentrations and independently of pH and drug configuration, suggesting a different mechanism of action compared with ClC-1. No effects were observed on ClC-5 that shows less than 30% homology with ClC-1. Thus, CPP-like compounds may be useful both to gain insight into biophysical properties of ClC-1 and for searching tissue-specific therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10953042     DOI: 10.1124/mol.58.3.498

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  23 in total

1.  Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels.

Authors:  G Zifarelli; A Liantonio; A Gradogna; A Picollo; G Gramegna; M De Bellis; A R Murgia; E Babini; D Conte Camerino; M Pusch
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Inhibition of ClC-2 chloride channels by a peptide component or components of scorpion venom.

Authors:  C H Thompson; D M Fields; P R Olivetti; M D Fuller; Z R Zhang; J Kubanek; N A McCarty
Journal:  J Membr Biol       Date:  2005-11       Impact factor: 1.843

Review 3.  Chloride channels as drug targets.

Authors:  Alan S Verkman; Luis J V Galietta
Journal:  Nat Rev Drug Discov       Date:  2008-01-19       Impact factor: 84.694

4.  Blocking pore-open mutants of CLC-0 by amphiphilic blockers.

Authors:  Xiao-Dong Zhang; Pang-Yen Tseng; Wei-Ping Yu; Tsung-Yu Chen
Journal:  J Gen Physiol       Date:  2008-12-15       Impact factor: 4.086

5.  Amphiphilic blockers punch through a mutant CLC-0 pore.

Authors:  Xiao-Dong Zhang; Tsung-Yu Chen
Journal:  J Gen Physiol       Date:  2008-12-15       Impact factor: 4.086

Review 6.  Novel diuretic targets.

Authors:  Jerod S Denton; Alan C Pao; Merritt Maduke
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

7.  Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1.

Authors:  Antonella Liantonio; Annamaria De Luca; Sabata Pierno; Maria Paola Didonna; Fulvio Loiodice; Giuseppe Fracchiolla; Paolo Tortorella; Laghezza Antonio; Elisabetta Bonerba; Sonia Traverso; Laura Elia; Alessandra Picollo; Michael Pusch; Diana Conte Camerino
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

8.  Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.

Authors:  Antonella Liantonio; Alessandra Picollo; Giuseppe Carbonara; Giuseppe Fracchiolla; Paolo Tortorella; Fulvio Loiodice; Antonio Laghezza; Elena Babini; Giovanni Zifarelli; Michael Pusch; Diana Conte Camerino
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-23       Impact factor: 11.205

9.  Intracellular proton regulation of ClC-0.

Authors:  Giovanni Zifarelli; Anna Rosa Murgia; Paolo Soliani; Michael Pusch
Journal:  J Gen Physiol       Date:  2008-07       Impact factor: 4.086

10.  Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression.

Authors:  S Pierno; G M Camerino; V Cippone; J-F Rolland; J-F Desaphy; A De Luca; A Liantonio; G Bianco; J D Kunic; A L George; D Conte Camerino
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.